King Pharma Allocates, Breaks
The $200 million term loan backing King Pharmaceuticals' acquisition of Alpharma allocated and broke for trading Dec. 19.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: